Vitamin D and COVID 19: The Evidence for Prevention and Treatment of Coronavirus (SARS CoV 2)

Vitamin D and COVID 19: The Evidence for Prevention and Treatment of Coronavirus (SARS CoV 2)

Evidence suggests that vitamin D supplementation could potentially be effective either in treatment or prevention of coronavirus disease 2019 (Covid‐19). Indeed, several studies and trials have begun to investigate the impact of vitamin D supplementation on patients with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. In this review, we focus on the potential mechanisms …

New Covid-19 strain features 17 mutations sparking fears vaccine won’t work

New Covid-19 strain features 17 mutations sparking fears vaccine won’t work

The new strain of Covid-19 has 17 mutations, scientists have discovered. UK experts have been analysing the new variant of coronavirus and say they have uncovered 17 alterations from the original strain of the killer disease, which they described as “a lot”. Many of the changes have happened to the virus’s spike protein, which it …

Nasdaq closes at all-time high after Fed’s decision

Nasdaq closes at all-time high after Fed’s decision

https://youtu.be/2ss4r6a5vAs US equities wavered on Wednesday as investors mulled the Federal Reserve’s policy update, disappointing economic data, and progress toward passing new stimulus.  Congressional leaders are close to agreeing on a stimulus package that includes just under $900 billion in relief funds, Politico reported. A deal could be finalized as early as Wednesday morning. Spending …

Goldman Sachs CEO says he’s concerned about stock-market euphoria stemming from retail investors

Goldman Sachs CEO says he’s concerned about stock-market euphoria stemming from retail investors

David Solomon told CNBC on Tuesday he’s concerned about euphoric activity in the stock market being driven by retail investors buying IPOs. “I do think we’re at a moment in time where there’s a lot of euphoria. I personally am concerned about that. I don’t think in the long run that’s healthy,” the Goldman Sachs …

FDA: Moderna vaccine meets expectations for emergency use

FDA: Moderna vaccine meets expectations for emergency use

Moderna’s vaccine could be administered to the public as early as next week if it wins emergency use authorization from the FDA. The FDA staff endorsement comes two days before the agency’s Vaccines and Related Biological Products Advisory Committee, a group of outside medical advisors, is scheduled to review it. The committee is expected to …

New Covid strain ripping through the South is forcing 11million more Brits into Tier 3 lockdowns

New Covid strain ripping through the South is forcing 11million more Brits into Tier 3 lockdowns

A NEW Covid strain which may spread even quicker is ripping through the South – as Matt Hancock last night plunged 11million more Brits into Tier 3. The Health Secretary told MPs more than 1,000 cases of the new “variant” has been discovered in up to 60 places across the UK – and the World …

US up premarket with Dow jumping over 170 pts

Equities on Wall Street climbed in the premarket trade on Monday as investors are eyeing updates on the coronavirus vaccine rollout as well as the COVID-19 stimulus gridlock in Washington. United States House Speaker Nancy Pelosi said in a phone call with Treasury Secretary Steve Mnuchin that during the coronavirus pandemic “the need for state …

Stimulus negotiations face a stormy week ahead

Stimulus negotiations face a stormy week ahead

Pressure to pass a last-ditch COVID-19 relief bill before the end of 2020 is coming from all sides. Is America any closer to a vote? By Monday evening, the bipartisan group of Senators that introduced a $908 billion proposal for emergency COVID-19 relief will have a fully fledged bill. Whether Congress will vote to pass …